These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23362315)

  • 21. Is silent myocardial infarction more common in women with type 2 diabetes than in men?
    Stiles MC; Seaquist ER; Yale JF; Green JB; Katz LA; Kempainen S; Light LS; Pepper PV; Zhang ZM; Soliman EZ
    J Diabetes Complications; 2012; 26(2):118-22. PubMed ID: 22446034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiographic QRS-T angle and the risk of incident silent myocardial infarction in the Atherosclerosis Risk in Communities study.
    Zhang ZM; Rautaharju PM; Prineas RJ; Tereshchenko L; Soliman EZ
    J Electrocardiol; 2017; 50(5):661-666. PubMed ID: 28515002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia detected by a treadmill exercise sestamibi stress test in patients with versus without diabetes mellitus.
    DeLuca AJ; Kaplan S; Aronow WS; Sandhu R; Butt A; Akoybyan A; Weiss MB
    Am J Cardiol; 2006 Oct; 98(8):1045-6. PubMed ID: 17027568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine.
    Herath HM; Weerarathna TP; Umesha D
    Vasc Health Risk Manag; 2015; 11():583-9. PubMed ID: 26622181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort.
    Keng MJ; Leal J; Mafham M; Bowman L; Armitage J; Mihaylova B
    Value Health; 2022 Mar; 25(3):435-442. PubMed ID: 35227456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of type 2 diabetes mellitus on recurrent myocardial infarction in China.
    Li W; Li M; Gao C; Wang X; Qi D; Liu J; Jin Q
    Diab Vasc Dis Res; 2016 Nov; 13(6):395-404. PubMed ID: 27390227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac Autonomic Dysfunction and Risk of Silent Myocardial Infarction Among Adults With Type 2 Diabetes.
    Kaze AD; Fonarow GC; Echouffo-Tcheugui JB
    J Am Heart Assoc; 2023 Oct; 12(20):e029814. PubMed ID: 37830346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES Study.
    Dohi T; Maehara A; Witzenbichler B; Rinaldi MJ; Mazzaferri EL; Duffy PL; Weisz G; Neumann FJ; Henry TD; Cox DA; Stuckey TD; Brodie BR; Litherland C; Brener SJ; Kirtane AJ; Mintz GS; Stone GW
    Circ Cardiovasc Interv; 2015 Dec; 8(12):e002447. PubMed ID: 26643737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
    Ritsinger V; Tanoglidi E; Malmberg K; Näsman P; Rydén L; Tenerz Å; Norhammar A
    Diab Vasc Dis Res; 2015 Jan; 12(1):23-32. PubMed ID: 25311248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia.
    Sejil S; Janand-Delenne B; Avierinos JF; Habib G; Labastie N; Raccah D; Vague P; Lassmann-Vague V
    Diabet Med; 2006 Nov; 23(11):1186-91. PubMed ID: 17054593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of subsequent myocardial infarction in patients with type 2 diabetes: a retrospective cohort study using the U.K. General Practice Research Database.
    Liang H; Vallarino C; Joseph G; Manne S; Perez A; Zhang S
    Diabetes Care; 2014; 37(5):1329-37. PubMed ID: 24595635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants.
    Millett ERC; Peters SAE; Woodward M
    BMJ; 2018 Nov; 363():k4247. PubMed ID: 30404896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative and positive predictive values of routine exercise testing in stable, medically-treated patients several years following a Q-wave myocardial infarction.
    Casella G; Pavesi PC; Niro MD; Bracchetti D
    Ital Heart J; 2001 Apr; 2(4):271-9. PubMed ID: 11374496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study.
    Zhang ZM; Rautaharju PM; Prineas RJ; Rodriguez CJ; Loehr L; Rosamond WD; Kitzman D; Couper D; Soliman EZ
    Circulation; 2016 May; 133(22):2141-8. PubMed ID: 27185168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals.
    Krarup NT; Borglykke A; Allin KH; Sandholt CH; Justesen JM; Andersson EA; Grarup N; Jørgensen T; Pedersen O; Hansen T
    Atherosclerosis; 2015 Jun; 240(2):305-10. PubMed ID: 25864160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multilevel socioeconomic status and incidence of frailty post myocardial infarction.
    Myers V; Drory Y; Goldbourt U; Gerber Y
    Int J Cardiol; 2014 Jan; 170(3):338-43. PubMed ID: 24275158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [United Kingdom Prospective Diabetes Study (UKPDS): 10 years later].
    Scheen AJ; Paquot N; Lefebvre PJ
    Rev Med Liege; 2008 Oct; 63(10):624-9. PubMed ID: 19009971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.
    Bangalore S; Bhatt DL; Steg PG; Weber MA; Boden WE; Hamm CW; Montalescot G; Hsu A; Fox KA; Lincoff AM
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):872-81. PubMed ID: 25271049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.
    Inglis SC; Bebchuk J; Al-Suhaim SA; Case J; Pfeffer MA; Solomon SD; Hou YR; Pitt B; Dargie HJ; Ford I; Kjekshus J; Zannad F; Dickstein K; McMurray JJ
    Int J Cardiol; 2013 Sep; 168(2):1094-101. PubMed ID: 23194780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.